Signify completes share repurchase program to cover performance share plans
Press Release
April 24, 2026
Signify completes share repurchase program to cover performance share plans
Eindhoven, The Netherlands – Signify (Euronext: LIGHT), the world leader in lighting, today announced that it has completed its previously announced share repurchase program.
The company repurchased a total of 725,000 shares for a total consideration of EUR 13.9 million from February 13 to April 23, 2026. These repurchases were made as part of the company’s repurchase program, which was announced on 13 February 2026. Signify will use the shares to cover obligations arising from its long-term incentive performance share plans and other employee share plans.
In the period April 20 to April 23, 2026, the company repurchased 13,050 shares at an average price of EUR 19.51 per share and an aggregate amount of EUR 0.3 million.
Details on the share buyback transactions can be found here.
--- END ---
For further information, please contact:
Signify Investor Relations
Thelke Gerdes
Tel: +31 6 1801 7131
E-mail: thelke.gerdes@signify.com
Signify Corporate Communications
Tom Lodge
Tel: +31 6 5252 5416
E-mail: tom.lodge@signify.com
About Signify
Signify (Euronext: LIGHT) is the world leader in lighting for professionals and consumers. We proudly bring to market the world’s best lighting brands, from Signify, Philips, Philips Hue, Signify Interact, Signify Dynalite, Color Kinetics and many more. Our advanced products, connected systems and services unlock the extraordinary potential of light for brighter lives and a better world. In 2025, we had sales of EUR 5.8 billion, approximately 27,000 employees, and a presence in over 70 markets. We are in the Dow Jones Sustainability World Index , earned a CDP ‘A’ score for climate performance and transparency and hold the EcoVadis Platinum rating.
News and updates from Signify can be found in the Newsroom, on LinkedIn and Instagram. Information for investors is located on the Investor Relations page.
Attachment
